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Abstract 
Purpose: To test the impact of a placebo drink on acute force production during isometric and 
isokinetic leg extensions in male and female college students. Methods: Nine male and five 
female subjects apparently healthy and free of leg injury completed familiarization testing and 
two counterbalanced trials. In one trial, participants were told they were consuming a 
performance-enhancing drink, although the drink contained only flavoring. In the other trial, 
participants were not given any drink (control). Both trials then included concentric and eccentric 
strength tests performed at 60 degrees per second, and isometric strength tests with the knee at a 
70 degree angle. A repeated-measures analysis of variance (ANOVA) was performed with 
treatment (placebo, control) and contraction (concentric, eccentric, isometric) as the within-
subjects effects. Post-hoc testing was performed using polynomial contrasts. Results: There was 
no significant treatment effect for the drink for concentric (132.9 ± 33.8 vs. 130.5 ± 35 Nm), 
isometric (139.7 ± 36.5 vs. 136.6 ± 28.9 Nm), or eccentric (190.9 ± 50.3 vs. 195.3 ± 55 Nm) 
quadriceps contractions compared to control, and no treatment x contraction interaction. 
Eccentric contractions exhibited significantly higher peak torque compared to concentric or 
isometric contractions (p < 0.05).  Conclusion: Findings suggest the placebo effect may not play 
a significant role in isokinetic or isometric contractions. Findings add to recent, but limited 
evidence that the placebo effect may not be as universal as currently thought. Future studies 
should investigate the difference between placebo-induced improvements of isotonic and 
isokinetic contractions. 
 
Keywords: Placebo effect, isokinetic contractions, expectancy effect, peak torque isokinetic, 
placebo effect for muscular strength, isokinetic placebo effect.  
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Chapter I 
Introduction 
Placebo Effect. The genuine psychological effect that results from receiving a substance or 
undergoing a procedure with no inherent powers is known as the placebo effect.1 It has been 
extensively studied in medicine, including the realms of depression, pain, surgical procedures, 
and pharmacological testing; however, its contributions to sports performance have not been 
heavily investigated until the last two decades.2  
Impact of Placebo on Muscular Strength. Three primary studies have evaluated the effect of a 
placebo on muscular strength. In a study by Maganaris et al. in 2000, national-level powerlifters 
gathered baseline one rep max data for the bench press, dead lift, and squat during 
familiarization trials, which closely resembled competitive conditions. Two experimental trials 
were performed during the following two weeks. For the first trial, all subjects were given two 
saccharin pills (described as immediate acting anabolic stimulators) five minutes before retesting 
the same three lifts. Compared to baseline values for the bench press, deadlift, and squat, the 
subjects experienced average improvements of 3.5%, 4.2%, and 5.2%, respectfully. Following 
completion of the first trial, one group of subjects was informed the pills only contained 
saccharin, and their performance expectedly dropped back to baseline values during the second 
trial one week later. The group that remained deceived, however, was able to keep their values 
for the three lifts significantly higher than baseline.3  
More recently, Kalasountas et al. (2007) found that male and female college non-athletes 
improved their strength by 10.2% for the machine bench press and 12% for the seated leg press 
from baseline values after consuming two placebo tablets 8-10 minutes before the first 
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experimental trial. The subjects were informed that the tablets consisted of strong combinations 
of amino acids that would produce immediate strength effects.4  
Dynamic muscle contractions are contractions involving eccentric (lengthening) and 
concentric (shortening) components, and can be classified as either isotonic (muscle tension is 
constant) or isokinetic (speed of contraction is constant). Maganaris et al. and Kalasountas et al. 
used isotonic contractions during their experiments. A study by Tallis et al. in 2016 used 
isokinetic contractions for maximal strength testing for 14 men. Contraction speeds for knee 
extension and flexion were tested at both 30 degrees/sec and 120 degrees/sec. For each 
participant, a familiarization trial was performed, and 4 counterbalanced experimental trials 
followed: (1) told caffeine, given caffeine; (2) told caffeine, given placebo; (3) told placebo, 
given placebo; and (4) told placebo, given caffeine. For both contraction speeds, Tallis et al. did 
not find an additional effect of the expectancy of caffeine.5  
Placebo Effect and Altered Cortical Activity. Although the precise mechanism regulating 
placebo-induced strength improvements is unknown, the expectancy theory provides a 
theoretical basis for understanding those strength responses to the placebo effect. The theory 
states the expectation for a given effect produces the biological response that underlies the effect 
by triggering pathways specific to the expectation.1,6 This is exemplified in patients with 
Parkinson’s disease, in which there was a dose-dependent relationship between the release of 
dopamine from the motor areas of the striatum and the magnitude of the patients’ perceived 
improvement in muscle control.7,8 Even small forces of muscular contractions have been shown 
to induce striatal dopamine release,9 but limited evidence exists related to the relationship 
between striatal dopamine release and maximal force production. In addition, in a pain analgesia 
study, the expectation of decreased pain triggered opioid release from the prefrontal cortical 
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structures, leading to decreased pain perception.10 It is unknown whether the opioid release 
transfers to motor functions, since opioids function mainly in the enteric nervous system.  
Muscle Contraction Type and Brain Activity. Interestingly, there are variations in the extent 
to which motor cortex activity is involved between isometric and dynamic (concentric and 
eccentric) muscle contractions. EEG, EMG, and fMRI data collection techniques have been used 
to show differences in motor cortex activity with the different types of contractions.11-14 Motor 
cortex activity (i.e. a- and b-band event-related desynchronization) is observed only at the onset 
of isometric contractions, whereas motor cortex activity appears to be sustained throughout 
dynamic contractions.11 This indicates greater excitability of cortical neurons during motor-
related brain functions for dynamic contractions.12 Further, comparing the types of dynamic 
contractions, greater brain activities in the primary motor cortex have been observed during 
eccentric contractions compared to concentric contractions by measuring activation volume by 
fMRI.13 If  brain activity is dependent on the contraction type, the type of contraction may dictate 
the magnitude of a placebo response by altering the neurological mechanisms responsible. 
Summary. To our knowledge, there is no prior research on the impact the placebo effect has 
between isometric and dynamic contractions. Discovery of variations in the placebo effect 
between isometric and dynamic contractions would lead to greater importance for controlling for 
the placebo effect in research studies. Further, if a supplement is tested against a placebo using 
dynamic contractions rather than isometric contractions, and is shown to be effective, consumers 
can be more confident in the efficacy of the product. The purpose of the present study is to 
compare the placebo effect between isometric and isokinetic muscle contractions. It is 
hypothesized that the placebo effect will be greater for isokinetic contractions compared to 
isometric contractions.	
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Chapter II 
Methods 
Participants. Twenty-four male and female participants will be recruited to voluntarily 
participate in this investigation. All participants will be apparently healthy and free of lower limb 
injury for the past 6 months before commencement of the study. Furthermore, participants will 
not exercise in the 48 hours leading up to testing protocols, and will perform a 10-hour fast 
preceding testing. Although the participants will not initially be informed of the true nature of the 
study, they will complete a university-approved informed consent explaining that the 
consumption of the ergogenic aid does not result in any health risks. Participants will be 
informed of the actual nature of the study after data collection is completed.  
Study Design. Participants will be told they are a part of a pilot study to test the impact of a 
caffeinated drink on concentric, isometric, and eccentric contractions. Although it will be 
described as a pilot study, the subjects will be instructed to give maximal effort during all tests. 
The placebo drink will be described as a supplement that positively impacts strength with 
minimal psychological effects. Two counterbalanced trials will take place for each participant. In 
one trial, the participants will consume the placebo drink, and they will perform the strength tests 
15 minutes after finishing a caffeine-free, calorie-free drink (bottled water with lemon flavoring). 
In a second trial, the participants will not consume anything, and they will perform the strength 
tests 15 minutes after being seated. For a warm-up, 10 repetitions of isokinetic leg extensions at a 
self-selected resistance not to exceed 50% of perceived capability will be completed 2 minutes 
before the strength tests. For both trials, concentric, isometric, and eccentric leg extension tests 
will occur. There will be 6 groups of 4 subjects for the purpose of counterbalancing the order so 
that every possible sequence of the concentric, isometric, and eccentric tests is given during the 
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study. Each participant will complete the trials during the same time of day within a week of 
each other, after completing a familiarization trial. 
Strength Test. The strength tests will be performed with the Biodex Isokinetic Dynamometer. 
Peak torque will be measured for each of the contraction types during 5 repetitions. The 
concentric and eccentric tests will be performed at 60 degrees per second, while isometric tests 
will be performed with the knee at a 70 degree angle. Five minutes of rest will be given between 
each contraction type. The peak torque readings for the trials will not be visible to the 
participant. 
Statistical Analysis. Percentage delta score for placebo effect [(perceived supplement - control 
condition)/control condition] will be calculated for each type of contraction. A repeated 
measures analysis of variance (ANOVA) will be performed to compare the delta scores for each 
type of contraction. Post hoc means comparisons will be performed using paired t-test with a 
Bonferroni correction.  A priori significance will be set at p < 0.05. 
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Chapter III 
Manuscript 
Introduction 
The placebo effect is the genuine psychological effect that results from receiving a 
substance or undergoing a procedure with no inherent powers.1 It has been extensively studied in 
medicine, including the realms of depression, pain, surgical procedures, and pharmacological 
testing; however, its contributions to sports performance have not been heavily investigated until 
the last two decades.2 Studies have shown improved muscular strength following consumption of 
placebo pills in isotonic exercises – concentric and eccentric exercises that keep a fixed amount 
of tension in the muscle – such as the bench press and leg extension.3,4 There has been one study 
that investigated placebo-induced force changes during isokinetic contractions – a specific type 
of muscular contraction that maintains movement speed by altering the resistance on the muscle.5 
This study did not observe an impact of a placebo on maximal muscular isokinetic strength. 
Unpublished findings from our lab indicate a 4.4% improvement in isometric peak force during a 
leg extension following consumption of a placebo drink.6  
The expectancy theory generalizes the mechanisms of the placebo effect, stating the 
expectation for a given effect produces the biological response that underlies the effect by 
triggering pathways specific to the expectation.1,7 This is exemplified in Parkinson’s Disease 
patients, in which the magnitude of patients’ perceived improvement in muscle control was 
correlated with the amount of dopamine release from the motor striatum.8,9 Additionally, the 
expectation of decreased pain has been shown to trigger opioid release from the prefrontal 
cortex, leading to decreased pain perception.10 Further, greater brain activities in the primary 
motor cortex have been observed during eccentric contractions compared to concentric 
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contractions, which may allow a greater neurological response to take place following the 
expectation of improved muscular force.11 Specifically, the heightened cortical activity could 
translate into a larger placebo effect. Discovery of variations in the placebo effect between 
isometric and dynamic muscle contractions would lead to greater importance for controlling for 
the placebo effect in research studies. The present study evaluated whether a placebo drink 
affects acute force production of isometric and isokinetic leg extensions.  
Methods 
Participants. Nine male and five female college age participants were recruited to participate in 
this investigation (mean ± SD height 174.9 ± 8.9 cm; body mass 75.6 ± 10.8 kg; BMI 24.7 ± 3.1 
kg/m2). All participants were screened using the 2019 Physical Activity Readiness Questionnaire 
for Everyone (See Appendix B), and were free of lower limb injury for the past six months 
before commencement of the study. Furthermore, participants did not exercise the leg muscles in 
the 48 hours leading up to testing protocols, and performed a 10-hour fast preceding testing. 
Although the participants were not initially informed of the true nature of the study, they 
completed a university-approved informed consent (See Appendix A), explaining that the 
consumption of the ergogenic aid does not result in any health risks. Participants were informed 
of the actual nature of the study after data collection was completed.  
Study Design. Participants were told they were part of a pilot study to test the impact of a 
caffeine-like drink on concentric, isometric, and eccentric contractions. Although it was 
described as a pilot study, the subjects were instructed to give maximal effort during all tests. 
The placebo drink was described as a supplement that positively impacts strength with minimal 
psychological effects. Two counterbalanced trials took place for each participant. In one trial, the 
participants believed they consumed the supplement, and they performed the strength tests 15 
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minutes after they finished a non-caffeinated drink (bottled water with non-caloric lemon 
flavoring). In a second trial, the participants did not consume any drink, and they performed the 
strength tests 15 minutes after they were seated. For a warm-up, 10 repetitions of isokinetic leg 
extensions at a self-selected resistance not to exceed 50% of perceived capability were 
completed 2 minutes before the strength tests. For both trials, concentric, isometric, and eccentric 
leg extension tests occurred. Test order was counterbalanced so that every possible sequence of 
the concentric, isometric, and eccentric tests, as well as the order of the placebo drink and no 
drink, was given during the study. Each participant completed the trials during the same time of 
day within a week of each other, after completing a familiarization trial. 
Strength Test. The strength tests were performed with the Biodex Isokinetic Dynamometer. 
Peak torque was measured for each of the contraction types during 5 repetitions. The concentric 
and eccentric tests were performed at 60 degrees per second, while isometric tests were 
performed with the knee at a 70 degree angle. Five minutes of rest were given between each 
contraction type. The peak torque readings for the trials were not visible to the participant. 
Statistical Analysis. Shapiro-Wilk tests confirmed that all outcome variables were normally 
distributed. A repeated-measures analysis of variance (ANOVA) was performed with treatment 
(placebo, control) and contraction (concentric, eccentric, isometric) as the within-subjects 
effects. Post-hoc testing was performed using polynomial contrasts. A priori significance was set 
at p < 0.05. 
Results 
Table 1 displays average ( ± SD) peak torque for each quadriceps contraction type, and 
the percent improvement for the placebo response to the drink. Eccentric flexion contractions 
exhibited significantly higher peak torque compared to concentric extension or isometric 
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contractions (p < 0.05). There was no significant treatment effect for the drink (p > 0.05). 
Furthermore, there was no treatment x contraction interaction (p > 0.05), suggesting that 
contraction type did not impact the magnitude of the placebo response in the present sample.  
Discussion 
The present study examined the effects of a placebo drink on the acute force production 
changes of isometric and isokinetic leg extensions in male and female college students. To our 
knowledge, this is the first study comparing the placebo effect between isometric and isokinetic 
contractions. Contrary to our hypothesis, the primary finding is that the placebo drink did not 
improve concentric, isometric or eccentric force production. These results contrast with findings 
of previous literature 2-4,6; however, the discrepancies may be explained by two main factors, 
which provide notable insight into the link between expectation and force production for skeletal 
muscle. 
First, isotonic tests were used in previous literature, whereas isokinetic tests were used in 
the present study. Both Maganaris et al. and Kalasountas et al. observed modest improvements 
among participants for isotonic compound exercises after consuming placebo pills.3,4 However, 
similar to the present study, Tallis et al. did not find a significant increase in maximal force 
production by a caffeine placebo for isokinetic contractions.5 Those findings, along with the 
present study are the only two studies that have examined the placebo effect under isokinetic 
conditions, and both did not observe a significant placebo effect. Thus, there may be a difference 
in the effectiveness of a placebo based on the type of muscular contraction. We speculate this 
may partly be due to the fact that people are more unfamiliar with isokinetic contractions than 
isotonic contractions. If participants are more focused on the unfamiliarity of a movement, it is 
possible they would be less focused on the expectancy of the placebo. In the current 
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investigation, both the drink and the no-drink conditions had significantly higher force 
production compared to the familiarization trial. This suggests isokinetic contractions may have 
been unfamiliar to the participants, thereby reducing the placebo effect.  
Second, there was a lack of subject-researcher relationship in the present study compared 
to the previous studies. In a study by Maganaris et al., subjects were national level powerlifters 
and the researchers were their coaches, so there was a high level of trust that had been developed 
between the subjects and the researchers.3 Likewise, Kalasountas et al. and Tallis et al. 
established authority and trust by recruiting subjects from beginner fitness courses and having 
degrees in the field.4,5 In the present study, however, most subjects were the same age and in the 
same university courses as the investigator administering the placebo drinks and regulating the 
tests. Thus, there may have been a low level of authority and trust in the efficacy of the drink by 
the participants. If true, participants would have a low expectation of the placebo effect, thereby 
reducing the biological mechanisms that underly its effect.7 
We observed the greatest peak torque for eccentric contractions, but the peak torque for 
isometric was not greater than that of concentric. This contrasts with current knowledge of 
isometric contractions producing greater force than concentric contractions.12 This may be 
explained by the low number of subjects. More subjects may have resulted in the difference in 
peak torque between those two types of contractions reaching statistical significance. 
Additionally, the low number of subjects in the present study may explain the non-significant 
placebo effect for isometric contractions, which contrast with unpublished findings from our 
lab.6 Similar methodologies were used between the previous study and the present study.  
Practically, data from the present study suggest the placebo effect is minimal for 
isokinetic strength tests. Thus, it could help future investigators to know there may be minimal 
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placebo effect with respect to improvements in peak isokinetic torque or isometric torque 
assessed on an isokinetic dynamometer. Strengths of the study include the counterbalanced 
design, and the use of isokinetic dynamometry – a criterion method of assessing muscle 
strength.13  The primary limitation of this study is the use of very specific types of contractions 
that are rarely used outside of research. The isokinetic contractions were performed at a specific 
speed, so it is unknown if the findings would be similar at different contraction speeds, or if they 
generalize to isotonic contractions. An additional limitation is the lack of trust and authority 
between the participants and the researcher, which may have decreased the expectancy effect. 
Finally, the low sample size in the present study may have contributed to a Type II error for 
either the main effect of placebo or the placebo x contraction interaction. However, it should be 
realized that the main effect for placebo and the interaction effect both exhibited small effect 
sizes (0.13 and 0.001 respectively). Future studies should add additional familiarization trials for 
isokinetic methods to minimize potential effects due to movement unfamiliarity, include various 
contraction speeds, and make sure the administer of the placebo drink is one who has authority 
and trust with participants. 
In conclusion, the current investigation did not find a greater placebo effect for dynamic 
contractions compared to isometric contractions, nor did it find an improvement in force 
production after consuming the placebo drink. This study adds contradictory evidence to the 
early placebo effect literature with respect to strength measures. Furthermore, it builds on recent, 
but limited, evidence that the placebo effect may not play a significant role in isokinetic 
contractions. 
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Table 1. Peak torque (N×m) for the no drink and drink treatments, and the percent improvement 
of the placebo response. 
  No Drink Drink % Improvement 
Contraction Type M SD M SD M SD 
Concentric Extension 130.5 35 132.9 33.8 3.4 13.8 
Isometric 136.6 28.9 139.7 36.5 1.7 10.4 
Eccentric Flexion* 195.3 55 190.9 50.3 -1.3 12.4 
 
*Main effect for contraction type (Eccentric Flexion > Isometric, Concentric Extension, p < 
0.05) 
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Appendix A 
Informed Consent Form
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Consent to Participate in Research 
 
Identification of Investigators & Purpose of Study   
You are being asked to participate in a research study conducted by Nick Antonacci and Dr. 
Womack from James Madison University.  The purpose of this study is to observe short-term 
strength responses to a performance supplement. This study will contribute to the completion of 
Nick Antonacci’s Honors Thesis.  
 
Research Procedures 
Should you decide to participate in this research study, you will be asked to sign this consent 
form once all your questions have been answered to your satisfaction.  This study consists of 
three visits to the Human Performance Laboratory in Godwin Hall, Room 209.  The first visit 
will be a familiarization trial, in which you will get used to the Biodex machine (the leg strength 
testing machine we will be using). The second and third visits will consists of 3 different 
maximal effort single-leg extensions after consuming either a performance supplement or 
nothing at all. Prior to the second and third visit, you will be asked to refrain from eating or 
drinking anything except water for 10 hours prior to the test (ex: no food/drink after 10pm if the 
test is at 8am the next day).  
 
Time Required 
Participation in this study will require 70 minutes of your time over the course of 3 weeks. The 
first session will take 10 minutes, while the last two sessions will take approximately 30 minutes 
each.   
 
Risks 
The investigator perceives the following are possible risks arising from your involvement with 
this study. Mild discomfort associated with maximal exertion of leg muscles. Research has 
shown that the rate of injury of strength training ranges between 0.24 – 5.5 injuries per 1000 
hours of training. Given that the involvement in our study is only 70 minutes and the leg 
extension is a safe, single-joint exercise, the risk of injury is even lower. In the highly unlikely 
event of a cardiac arrest, at least 1 CPR-trained investigator will be present at every test.  
 
Benefits 
Potential benefits from participation in this study include feedback on your current level of 
single-leg peak torque (an indicator of lower limb strength), and knowledge of how your body 
responds to short-term performance enhancing supplements. 
 
Confidentiality  
The results of this research will be presented at JMU conferences and may appear in online 
research journals. The results of this project will be coded in such a way that the respondent’s 
identity will not be attached to the final form of this study.  The researchers retain the right to use 
and publish non-identifiable data.  While individual responses are confidential, aggregate data 
will be presented representing averages or generalizations about the responses as a whole.  All 
data will be stored in a secure location accessible only to the researcher.  Upon completion of the 
study, all information that matches up individual respondents with their answers will be 
destroyed. 
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Participation & Withdrawal  
Your participation is entirely voluntary.  You are free to choose not to participate.  Should you 
choose to participate, you can withdraw at any time without consequences of any kind. 
 
Questions about the Study 
If you have questions or concerns during the time of your participation in this study, or after its 
completion or you would like to receive a copy of the final aggregate results of this study, please 
contact: 
 
Nick Antonacci              Christopher Womack 
Department of Kinesiology   Department of Kinesiology 
James Madison University   James Madison University 
antonanv@dukes.jmu.edu    Telephone:  (540) 568-6515 
womackcx@jmu.edu 
 
Questions about Your Rights as a Research Subject 
Dr. Taimi Castle  
Chair, Institutional Review Board 
James Madison University 
(540) 568-5929 
castletl@jmu.edu 
  
Giving of Consent 
I have read this consent form and I understand what is being requested of me as a participant in 
this study.  I freely consent to participate.  I have been given satisfactory answers to my 
questions.  The investigator provided me with a copy of this form.  I certify that I am at least 18 
years of age. 
 
______________________________________     
Name of Participant (Printed) 
 
______________________________________    ______________ 
Name of Participant (Signed)                                    Date 
 
______________________________________    ______________ 
Name of Researcher (Signed)                                   Date 
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Appendix C 
Debriefing Script
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Debriefing Script 
Thank you for participating in our caffeine study. I would like to explain to you more about 
exactly what we were trying to study. Sometimes the scientific process requires that the 
participants in research studies are not given complete information about the nature of the study 
until after the study is completed. If we tell people the true purpose of a study, it may influence 
their performance in the study. 
 In our study, we wanted to test the placebo effect for various types of leg contractions. The 
placebo effect is the psychological effect that results from believing a substance or procedure 
will have an impact, even though it has no inherent powers. When you were told you were 
consuming caffeine, it was truly flavored water. You never consumed caffeine during the study. 
This way, we were able to see if your force production was affected by your belief of improving 
performance.  
Now that the study has been explained, do you allow us to use the data from your participation? 
 
If you have any other questions later feel free to contact us* 
*Names and phone numbers for Principal Investigator and Faculty Advisor will be provided. 
Thanks again for your participation! 
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